◆英語タイトル：Actinium Pharmaceuticals Inc (ATNM) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company’s pipeline products include Iomab-B for hematopoietic stem cell transplantation, Iomab-ACT for the treatment of GeneTx and Cell therapy conditioning, and Actimab-M CD33 for Multiple Myeloma. Actinium through its product Iomab-B via the monoclonal antibody BC8, targets CD45, an antigen widely expressed on leukemia and lymphoma cancer cells, B cells and stem cells. The company also offers AWE Technology Platform. It develops products to treat colon, prostrate and brain cancer. ATNM is headquartered in New York, the US.
Actinium Pharmaceuticals Inc Key Recent Developments
Mar 25,2021: Actinium Announces Completion of Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial for Patients with R/R AML
Mar 03,2021: Actinium announces appointment of Mark Kubik, MBA as chief business officer
Feb 11,2021: Actinium Showcases Targeted Conditioning Program with 2 Oral Presentations Highlighting Iomab-B and Pivotal Phase 3 SIERRA Trial at 2021 Transplantation & Cellular Therapy Annual Meeting
Feb 10,2021: Actinium Announces Participation in BIO CEO & Investor Digital Conference
Jan 13,2021: Astellas announces a research collaboration with Actinium for molecular targeted radiotherapy
This comprehensive SWOT profile of Actinium Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Actinium Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Actinium Pharmaceuticals Inc – Key Information
Actinium Pharmaceuticals Inc – Overview
Actinium Pharmaceuticals Inc – Key Employees
Actinium Pharmaceuticals Inc – Key Employee Biographies
Actinium Pharmaceuticals Inc – Key Operational Heads
Actinium Pharmaceuticals Inc – Major Products and Services
Actinium Pharmaceuticals Inc – History
Actinium Pharmaceuticals Inc – Company Statement
Actinium Pharmaceuticals Inc – Locations And Subsidiaries
Actinium Pharmaceuticals Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Actinium Pharmaceuticals Inc – Business Description
Actinium Pharmaceuticals Inc – Corporate Strategy
Actinium Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Actinium Pharmaceuticals Inc – Strengths
Actinium Pharmaceuticals Inc – Weaknesses
Actinium Pharmaceuticals Inc – Opportunities
Actinium Pharmaceuticals Inc – Threats
Actinium Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Actinium Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Actinium Pharmaceuticals Inc, Key Information
Actinium Pharmaceuticals Inc, Key Ratios
Actinium Pharmaceuticals Inc, Share Data
Actinium Pharmaceuticals Inc, Major Products and Services
Actinium Pharmaceuticals Inc, History
Actinium Pharmaceuticals Inc, Key Employees
Actinium Pharmaceuticals Inc, Key Employee Biographies
Actinium Pharmaceuticals Inc, Key Operational Heads
Actinium Pharmaceuticals Inc, Other Locations
Actinium Pharmaceuticals Inc, Subsidiaries
Actinium Pharmaceuticals Inc, Key Competitors
Actinium Pharmaceuticals Inc, SWOT Analysis
Actinium Pharmaceuticals Inc, Ratios based on current share price
Actinium Pharmaceuticals Inc, Annual Ratios
Actinium Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Actinium Pharmaceuticals Inc (ATNM)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら